Per joined Ferring Pharmaceuticals in 2015 and was appointed President on January 1st 2019.
He previously held executive and senior leadership positions in research, medical and clinical development at Novo Nordisk and AstraZeneca.
Before joining industry, he held the position of Associate Professor at the Karolinska Institute, Sweden, and Washington University School of Medicine, USA. Per has an M.D. degree and a Ph.D. in Biochemistry and Clinical Chemistry from Gothenburg University, Sweden.